Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
Phase 1 study (DRAGON) of SRK-181 (linavonkibart), a latent TGFβ1 inhibitor, combined with pembrolizumab in patients with anti-PD1 resistant advanced solid tumors: Updated results of expansion part
Meeting Abstract
Overview
Research
Additional Document Info
View All
Overview
cited authors
Vaishampayan, Ulka N.; Sweis, Randy F.; Kilari, Deepak; Tarhini, Ahmad A.; Gainor, Justin F.; Barve, Minal A.; Sonpavde, Guru P.; McKean, Meredith; Park, David J.; Babu, Sunil; Ju, Yawen; Liu, Lan; Henry, Susan; Gan, Lu; Yap, Timothy A.
Publication Date
June 1, 2024
webpage
Web of Science
published in
JOURNAL OF CLINICAL ONCOLOGY
Journal
Research
category
ONCOLOGY
Web of Science Category
Additional Document Info
volume
42
issue
16